FitLife Brands, Inc. (FTLF) 股票分析

公司概述

FitLife Brands, Inc. operates within the Consumer Defensive sector, specifically serving the Packaged Foods industry by offering nutritional supplements and wellness products to health-conscious consumers in the United States and international markets. The company's product portfolio focuses on weight loss, sports nutrition, general health, and wellness items that emphasize natural, vegan, and organic attributes. As of the latest data, the enterprise holds a market capitalization of $92.69M and employs 81 individuals to support its operations. With annual revenue reaching $81.46M, the company's valuation suggests a small-cap classification, indicating it operates with a relatively limited scale compared to large-cap peers in the broader consumer goods landscape. This market position implies that the firm is a niche player whose financial performance is highly sensitive to fluctuations in consumer demand for specific wellness categories rather than broad macroeconomic shifts affecting the entire sector.

财务健康

The company reported a trailing twelve-month revenue of $81.46M, generating a net income of $6.33M and an EBITDA of $13.60M during the same period. The significant gap between the $81.46M revenue and the $6.33M net income reveals a cost structure where operating expenses, including cost of goods sold and administrative costs, consume approximately 92.2% of total revenue before arriving at the bottom line. However, the EBITDA figure of $13.60M indicates that the company generates substantial operating cash flow before interest, taxes, depreciation, and amortization, suggesting underlying operational efficiency before financing decisions. Conversely, the free cash flow stands at -$1,449,625, which signals a temporary lack of financial flexibility where cash outflows for capital expenditures or working capital changes exceed operating cash generation. The gross margin is recorded at 39.9%, reflecting a pricing power or cost advantage in sourcing ingredients for its packaged food products. The operating margin of 12.1% and profit margin of 7.8% further delineate the efficiency of the company in converting sales into operational and net earnings respectively. On the balance sheet, cash holdings of $1.65M are substantially lower than the total debt of $45.27M, resulting in a debt-to-equity ratio of 103.75%. This leverage profile indicates that the company is heavily financed by debt relative to equity, which could amplify financial risk if interest rates rise or cash flows decline. Despite the high leverage, the current ratio of 1.53 suggests that the company maintains adequate short-term liquidity, as its current assets are 1.53 times greater than its current liabilities. Furthermore, the return on equity is 15.9% while the return on assets is 10.0%, indicating that management is effectively utilizing shareholder equity to generate returns, although the asset base is burdened by significant debt obligations.

估值评估

The stock trades with a trailing P/E ratio of 15.67 and a forward P/E of 5.42, implying that the market expects a substantial increase in earnings growth to justify the lower forward multiple. The disparity between the trailing and forward P/E ratios suggests analysts anticipate a significant turnaround or acceleration in profitability over the coming fiscal periods. The price-to-book ratio is 2.12, indicating that the market values the company at more than double its book value, which may reflect expectations of intangible asset growth or brand equity in the wellness sector. Alternative valuation metrics show a price-to-sales ratio of 1.14 and an EV/EBITDA of 10.02, suggesting that the company is valued slightly at par with its sales while maintaining a moderate multiple relative to its earnings before interest, taxes, depreciation, and amortization. Regarding price momentum, the 52-week high is $20.98 and the 52-week low is $9.71, providing a clear range for historical volatility. Without the specific current share price listed in the available facts, the precise percentage position relative to the high and low cannot be calculated, but the range demonstrates a wide trading band typical of small-cap stocks with high beta. The beta value is 0.38, which indicates that the stock's price volatility is significantly lower than the broader market, making it a defensive holding relative to high-beta equities.

Growth & Income

The company experienced a revenue growth rate of 72.6% year-over-year, while earnings growth declined by 23.8% over the same period. This divergence implies that revenue expansion is not being fully translated into bottom-line profitability, likely due to the high leverage structure or one-time costs impacting the net income figure. As the dividend yield is N/A and the payout ratio is 0.0%, the company does not distribute cash to shareholders, indicating a strategy of retaining earnings to fund operations, repay debt, or invest in product development rather than paying dividends. The absence of a dividend payout suggests that management prioritizes solvency and operational reinvestment over current income generation for investors. The overall growth and income profile reflects a high-revenue-growth, non-dividend-paying entity with significant earnings volatility and a leveraged capital structure, characteristic of a company in a scaling phase that requires substantial capital deployment to sustain its expansion trajectory.